2-202556360-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001204.7(BMPR2):c.2695C>T(p.Arg899*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001204.7 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727230
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pulmonary hypertension, primary, 1 Pathogenic:3
The nonsense variant c.2695C>T (p.Arg899X) was detected in heterozygosis in the patient, who was diagnosed with hereditary PAH due to having an affected relative (nephew). The variant is not reported in the gnomAD population database. Arg899X has been demonstrated non-critical/not necessary for kinase activity based on the criteria of the ClinGen Pulmonary Hypertension Expert Panel (https://cspec.genome.network/cspec/ui/svi/doc/GN125). ClinVar classifies this variant as Pathogenic, 2 stars (reviewed Nov '24, 7 submissions). Based on available information, this variant is considered to be pathogenic. -
- -
- -
Pulmonary arterial hypertension Pathogenic:1
- -
Pulmonary venoocclusive disease 1;C4552070:Pulmonary hypertension, primary, 1 Pathogenic:1
- -
not provided Pathogenic:1
The BMPR2 c.2695C>T; p.Arg899Ter variant (rs137852741) is reported in the literature in multiple individuals affected with PAH (International PPH Consortium 2000, Machado 2009). This variant is also absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000 Sep;26(1):81-4. Machado RD et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S32-42. -
Primary pulmonary hypertension Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg899*) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with pulmonary hypertension (PMID: 10973254, 11115378, 15146475, 19555857, 21737554, 21801371, 23592887). In at least one individual the variant was observed to be de novo. Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this BMPR2 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 19,619 individuals referred to our laboratory for BMPR2 testing. ClinVar contains an entry for this variant (Variation ID: 8796). For these reasons, this variant has been classified as Pathogenic. -
Pulmonary arterial hypertension;C5679820:Idiopathic and/or familial pulmonary arterial hypertension Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at